Mays Tawayha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mays Tawayha has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Manoj Sharma
Department of Internal Medicine, Mercy Hospital of Buffalo, University at Buffalo, Buffalo, NY 14220, USA
2 shared publications - Wassim Mosleh
Department of Interventional Cardiology, Mercy Hospital of Buffalo, University at Buffalo, Buffalo, NY 14220, USA
2 shared publications - Ahmed Ali
Department of Internal Medicine, Mercy Hospital of Buffalo, University at Buffalo, Buffalo, NY 14220, USA
1 shared publication - Aliza Yaqub
Department of Internal Medicine, Mercy Hospital of Buffalo, University at Buffalo, Buffalo, NY 14220, USA
1 shared publication Christopher J. Wilcox
University at Buffalo, SUNY, Mercy Hospital of Buffalo, Department of Critical Care Buffalo, NY, USA
1 shared publicationCraig Vitrano
Occupational Medicine, Buffalo, NY, USA
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (19) , 7586
Factors Associated with Invasive Coronary Angiography Use in Type 2 Myocardial Infarction: A Systematic Review with Narrative Synthesis
Background/Objectives: Type 2 myocardial infarction (T2MI) results from a myocardial oxygen supply–demand imbalance without acute coronary atherothrombosis, and the role of invasive coronary angiography in its management is undefined. Prior literature has largely compared T2MI to type 1 myocardial infarction (T1MI) rather than examining angiography selection within T2MI itself. This systematic review with narrative synthesis identified and synthesized factors associated with angiography utilization among T2MI patients, distinguishing adjusted from unadjusted evidence. Methods: PubMed, Embase, and ClinicalTrials.gov were searched for studies reporting patient or clinical characteristics associated with undergoing invasive coronary angiography among patients with T2MI, identified via multivariable regression, univariate comparison, or stratified baseline tables. Studies using angiography as an inclusion criterion, an event-risk outcome, or a randomized treatment assignment, or comparing T2MI to T1MI as groups without addressing within-T2MI factors, were excluded. This review was conducted in accordance with PRISMA 2020 guidance. Given clinical and methodological heterogeneity and no common effect-size metric across studies, findings were synthesized narratively without quantitative pooling. Results: Three studies met inclusion criteria (two large US administrative-data cohorts, n = 268,850 and n = 18,606 T2MI; one French two-center cohort, n = 224). Younger age was independently associated with greater odds of angiography in the largest cohort reporting age-specific estimates, with a monotonic decline in angiography utilization across advancing age strata; a second cohort’s unadjusted group comparison was directionally concordant, but its own multivariable estimate for age was internally inconsistent and is not treated as confirmatory. Chronic ischemic heart disease and heart failure were independently associated with higher odds of angiography, while chronic kidney disease, chronic obstructive pulmonary disease, peripheral vascular disease, and atrial fibrillation were independently associated with lower odds. Commercial insurance and Midwest or South United States residence were independently associated with higher odds in the single study assessing these factors. Cardiology consultation showed conflicting directions of adjusted association between the two studies reporting it. Conclusions: Selection for invasive angiography in T2MI is heterogeneous and inconsistently studied. Age was the only factor with cross-study directional support, and even that lacked confirmed adjusted concordance. Other factors were supported by single studies or conflicting findings, and no included study reported the bedside clinical variables plausibly driving real-time decisions. Certainty was very low for every factor examined (modified GRADE), underscoring the need for prospective study of angiography selection in T2MI.
- 30 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (19) , 7586
Open AccessFactors Associated with Invasive Coronary Angiography Use in Type 2 Myocardial Infarction: A Systematic Review with Narrative Synthesis
Background/Objectives: Type 2 myocardial infarction (T2MI) results from a myocardial oxygen supply–demand imbalance without acute coronary atherothrombosis, and the role of invasive coronary angiography in its management is undefined. Prior literature has largely compared T2MI to type 1 myocardial infarction (T1MI) rather than examining angiography selection within T2MI itself. This systematic review with narrative synthesis identified and synthesized factors associated with angiography utilization among T2MI patients, distinguishing adjusted from unadjusted evidence. Methods: PubMed, Embase, and ClinicalTrials.gov were searched for studies reporting patient or clinical characteristics associated with undergoing invasive coronary angiography among patients with T2MI, identified via multivariable regression, univariate comparison, or stratified baseline tables. Studies using angiography as an inclusion criterion, an event-risk outcome, or a randomized treatment assignment, or comparing T2MI to T1MI as groups without addressing within-T2MI factors, were excluded. This review was conducted in accordance with PRISMA 2020 guidance. Given clinical and methodological heterogeneity and no common effect-size metric across studies, findings were synthesized narratively without quantitative pooling. Results: Three studies met inclusion criteria (two large US administrative-data cohorts, n = 268,850 and n = 18,606 T2MI; one French two-center cohort, n = 224). Younger age was independently associated with greater odds of angiography in the largest cohort reporting age-specific estimates, with a monotonic decline in angiography utilization across advancing age strata; a second cohort’s unadjusted group comparison was directionally concordant, but its own multivariable estimate for age was internally inconsistent and is not treated as confirmatory. Chronic ischemic heart disease and heart failure were independently associated with higher odds of angiography, while chronic kidney disease, chronic obstructive pulmonary disease, peripheral vascular disease, and atrial fibrillation were independently associated with lower odds. Commercial insurance and Midwest or South United States residence were independently associated with higher odds in the single study assessing these factors. Cardiology consultation showed conflicting directions of adjusted association between the two studies reporting it. Conclusions: Selection for invasive angiography in T2MI is heterogeneous and inconsistently studied. Age was the only factor with cross-study directional support, and even that lacked confirmed adjusted concordance. Other factors were supported by single studies or conflicting findings, and no included study reported the bedside clinical variables plausibly driving real-time decisions. Certainty was very low for every factor examined (modified GRADE), underscoring the need for prospective study of angiography selection in T2MI.
- 26 August 2026
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
VV-ECMO Support in Acute Respiratory Failure from Occupational Phosgene Gas Exposure: A Case Report
A 56-year-old male with no antecedent respiratory disease developed acute respiratory failure following workplace exposure to phosgene gas (COCl₂), a toxic industrial compound known for its pulmonary toxicity. He developed refractory hypoxemia, was transferred to our facility, and was promptly placed on venovenous extracorporeal membrane oxygenation (VV-ECMO). The patient was successfully supported through the acute lung injury and recovery phase and was discharged from the hospital within 16 days without supplemental oxygen. To our knowledge, this is the first known case in the United States of the use of ECMO in the treatment of phosgene gas exposure. Currently, there are few evidence-based therapeutic options available for phosgene gas exposure; however, it is suggested that supportive care may allow for physiological recovery. Previous reports have suggested that VV-ECMO can improve survival in cases of treatment-resistant hypoxemia.
- 26 August 2026
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
VV-ECMO Support in Acute Respiratory Failure from Occupational Phosgene Gas Exposure: A Case Report
A 56-year-old male with no antecedent respiratory disease developed acute respiratory failure following workplace exposure to phosgene gas (COCl₂), a toxic industrial compound known for its pulmonary toxicity. He developed refractory hypoxemia, was transferred to our facility, and was promptly placed on venovenous extracorporeal membrane oxygenation (VV-ECMO). The patient was successfully supported through the acute lung injury and recovery phase and was discharged from the hospital within 16 days without supplemental oxygen. To our knowledge, this is the first known case in the United States of the use of ECMO in the treatment of phosgene gas exposure. Currently, there are few evidence-based therapeutic options available for phosgene gas exposure; however, it is suggested that supportive care may allow for physiological recovery. Previous reports have suggested that VV-ECMO can improve survival in cases of treatment-resistant hypoxemia.
- Open Access
Paradoxical Coronary Artery Embolism Through a Patent Foramen Ovale in a Young Adult
We describe the case of a 26-year-old man who presented with acute chest pain and was found to have single-vessel coronary occlusion most consistent with probable paradoxical embolism. Coronary angiography demonstrated complete occlusion of the ramus intermedius artery. Aspiration thrombectomy restored flow without stent implantation. Intravascular ultrasound showed no plaque rupture, atherosclerosis, or coronary dissection, supporting but not definitively confirming an embolic etiology. Transthoracic and transesophageal echocardiography subsequently identified a large patent foramen ovale with bidirectional shunting. Lower-extremity Doppler studies and an extensive hypercoagulable evaluation were negative. The patient later underwent successful percutaneous closure of the patent foramen ovale. This case highlights probable paradoxical coronary embolism as a rare cause of acute myocardial infarction in a young patient without significant atherosclerotic disease and underscores the value of multimodality imaging in supporting the diagnosis and guiding management.
Open AccessParadoxical Coronary Artery Embolism Through a Patent Foramen Ovale in a Young Adult
We describe the case of a 26-year-old man who presented with acute chest pain and was found to have single-vessel coronary occlusion most consistent with probable paradoxical embolism. Coronary angiography demonstrated complete occlusion of the ramus intermedius artery. Aspiration thrombectomy restored flow without stent implantation. Intravascular ultrasound showed no plaque rupture, atherosclerosis, or coronary dissection, supporting but not definitively confirming an embolic etiology. Transthoracic and transesophageal echocardiography subsequently identified a large patent foramen ovale with bidirectional shunting. Lower-extremity Doppler studies and an extensive hypercoagulable evaluation were negative. The patient later underwent successful percutaneous closure of the patent foramen ovale. This case highlights probable paradoxical coronary embolism as a rare cause of acute myocardial infarction in a young patient without significant atherosclerotic disease and underscores the value of multimodality imaging in supporting the diagnosis and guiding management.